Credit: CC0 Public Domain Fentanyl, a powerful synthetic opioid implicated in nearly 29,000 overdose deaths in the United States last year, most likely spread because of heroin and prescription pill shortages, and also because it was cheaper for drug wholesalers than heroin, according to a report on illicit US drug markets by researchers at UC […]Continue Reading ...
Credit: CC0 Public Domain Opioid overdose deaths hit the highest level ever recorded in the United States last year, with an estimated 200 people dying per day, according to a report by the U.S. Drug Enforcement Administration. Preliminary figures show more than 72,000 people died in 2017 from opioid-related overdoses across the country. About a […]Continue Reading ...
We’ve also seen a rise in “off-label” prescription of pregabalin. This means it’s being prescribed for conditions for which there is limited evidence of effectiveness. Pregabalin is often prescribed for chronic or persisting pain, for example, even when there is no clear nerve-related cause. Pregabalin is thought to have effects in the brain similar to […]Continue Reading ...
Credit: CC0 Public Domain In response to the opioid crisis, all 50 states have changed their laws to make naloxone, the overdose reversal drug, easier to get and use. Many states have issued standing medication orders so pharmacists can dispense the life-saving antidote without a prescription. Cities such as Philadelphia have campaigns encouraging family and […]Continue Reading ...
Credit: 123RF.com/Rice University Most government-funded initiatives to address the overdose epidemic in the United States have targeted opioids specifically and have neglected other drugs that are increasingly implicated in overdoses, such as cocaine and methamphetamine, according to an issue brief by a drug policy expert at Rice University’s Baker Institute for Public Policy. “The Drug […]Continue Reading ...
Pain medication such as oxycodone often helps cancer patients deal with intense pain after treatment, but it also can lead to abuse. Credit: Steve Heal/Shutterstock.com The availability of life-prolonging treatments such as hormonal therapies and other targeted chemotherapy has led to a sharp decline in breast cancer deaths in the United States. But despite these […]Continue Reading ...
This undated product image provided by Genentech shows a box for Xofluza, a pill for shortening the duration and easing symptoms of the flu. U.S. health regulators have approved the first new type of flu drug in two decades. The approval on Wednesday, Oct. 24, 2018, of Roche’s Xofluza comes ahead of this winter’s flu […]Continue Reading ...
Michael Fendrich, associate dean for research and professor at the School of Social Work, on Oct. 12, 2018. Credit: Sean Flynn/UConn Photo Michael Fendrich is associate dean for research and a professor in the UConn School of Social Work, whose research focuses on policies, services, interventions, and risk factors related to substance misuse and mental […]Continue Reading ...
Credit: CC0 Public Domain Someday doctors may prescribe sugar pills for certain chronic pain patients based on their brain anatomy and psychology. And the pills will reduce their pain as effectively as any powerful drug on the market, according to new research. Northwestern Medicine scientists have shown they can reliably predict which chronic pain patients […]Continue Reading ...
Credit: CC0 Public Domain They may start as well-intentioned efforts to calm anxiety, improve sleep or ease depression. But prescriptions for sedatives known as benzodiazepines may lead to long-term use among one in four older adults who receive them, according to new research. That’s despite warnings against long-term use of these drugs, especially among older […]Continue Reading ...
When the retail price of a drug is less than the amount of a patient’s copay, the surplus is usually absorbed by pharmacy benefit managers, according to a recent USC study. Credit: iStock Prescription drug copayments often exceed the retail cost of a drug, a recent USC study reveals. This means that technically an overpayment […]Continue Reading ...
(HealthDay)—Rare but serious genital infections, as well as one death, have been reported in some patients taking a certain class of type 2 diabetes medicine, the U.S. Food and Drug Administration says. As a result, the FDA has ordered a new warning about this risk to be added to the prescribing information and patient medication […]Continue Reading ...
With the support of the National Institute on Drug Abuse, scientists at Wake Forest School of Medicine have been working to find a safe, non-addictive pain killer to help fight the current opioid crisis in this country. And they may have done just that, though in an animal model. Known as AT-121, the new chemical […]Continue Reading ...
Credit: CC0 Public Domain Stanford University researchers have developed a mathematical model that could help public health officials and policymakers curb an opioid epidemic that took the lives of an estimated 49,000 Americans last year. The model includes data about prescriptions, addictions and overdoses in the United States. It can be used to consider “what […]Continue Reading ...
Emily Lindemer and her team created the “Hey, Charlie” app for recovering addicts. As users go about their day, if they approach a place they have signified as risk-related, the app sends a notification: “Hey, I know you’re near a risky area. You can do this.” Credit: Lillie Paquette In the spring of 2016, while […]Continue Reading ...
- Pregnancy in adolescence linked to increased risks of complications in young mothers
- Risk Analysis publishes special issue on communicating about Zika virus
- Botox May Help Prevent Post-Op A-Fib
- African-American mothers rate boys higher for ADHD
- Graphic warning labels cancel out cigarettes’ appeal to young people
- Australian researchers to study gas inhalational anaesthetic and likelihood of cancer return
- Individual neurons located within the brain have implications for psychiatric diseases
- Researchers improve bariatric surgery scoring system to extend prediction time for diabetic remission
- Combo therapy not needed if low RA disease activity achieved
- Novel therapeutic targets based on biology of aging show promise for Alzheimer’s disease
- UC San Diego professor receives NCI Outstanding Investigator Award for cancer research
- Study evaluates placental mesenchymal stem cell sheets for myocardial repair and regeneration
- Blueprint Medicines Announces Updated Results from Ongoing EXPLORER Clinical Trial of Avapritinib Demonstrating Broad Clinical Activity and Significant Symptom Reductions in Patients with Systemic Mastocytosis
- Study clarifies ApoE4’s role in dementia
- Eating disorders now a top priority with Australian Government
- Neuronal activity in the brain allows prediction of risky or safe decisions
- FDA Alerts Health Care Professionals and Patients Not to Use Drug Products Intended to be Sterile from Promise Pharmacy
- Improving dementia care and treatment saves thousands of pounds in care homes
- Heroin-assisted treatment can offer benefits, reduce harms
- People covered by Michigan’s expanded Medicaid program report improvements in health, finds study